Medical Device News Magazine

FX Solutions Receives FDA 510(k) Clearance for Lateralized & Augmented Glenoid Baseplates

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • With the launch of the lateralized glenoid baseplates FX will include upgrades of their current instrumentation to include a first-to-market and completely unique patent-pending trialing system for the reverse glenoid construct.

FX Solutions received 510k clearance for its lateralized and augmented glenoid baseplates. With these additions, FX brings ten additional glenoid baseplate options to the market.

 

The glenoid baseplates are available in 24mm options with additional lateralization, augments, and lateralized augments. The lateralized glenoid baseplates are available with a central screw or central post option. The augmented glenoid baseplates are available with the central screw option only.

The Humelock glenoid baseplate is a 24mm round baseplate available in four options: baseplate with a central cannulated post, baseplate with a central screw (with seven 4.5mm central screw length options from 8-20mm in 2mm increments), lateralized baseplate with +3mm or +6mm added, and augmented baseplate with 7.5° (3mm thick) or 15° (6.5mm thick) half-wedge added, +0, +3mm, or +6mm lateralized. Lateralization and augmentation are added under the flat surface of the baseplate and above the post.

“As we continue to grow the FX portfolio, we evolve ever closer to providing a tailor-made approach for surgeons using our portfolio. They may be able to adapt the system to the patient rather than the patient to our system. This clearance of the lateralized and augmented glenoid baseplates is truly significant for our portfolio and the treatment of patients’ shoulders,” said Baptiste Martin, CEO of FX Shoulder USA.

With the launch of the lateralized glenoid baseplates FX will include upgrades of their current instrumentation to include a first-to-market and completely unique patent-pending trialing system for the reverse glenoid construct. This features a monobloc trial consisting of the glenosphere and lateralized glenoid baseplate together to better replicate the feel of the definitive implants.

FX continues to innovate based upon surgeon feedback and market trends with a focus exclusively on shoulder arthroplasty with the goal of becoming a global market leader in this segment.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.